339186-68-4 Usage
General Description
Matuzumab is a monoclonal antibody that targets the epidermal growth factor receptor (EGFR) and is being investigated for its potential use in the treatment of various types of cancer. It works by binding to the EGFR on the surface of cancer cells, preventing the receptor from signaling the cells to grow and divide. This can help slow the progression of cancer and improve patient outcomes. Matuzumab is being studied in clinical trials for its efficacy in treating lung, head and neck, and other types of cancers, and early results have shown promising potential for its use in cancer therapy. Additionally, Matuzumab has been found to have a good safety profile and tolerability in patients, making it a potentially valuable treatment option in the fight against cancer.
Check Digit Verification of cas no
The CAS Registry Mumber 339186-68-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,3,9,1,8 and 6 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 339186-68:
(8*3)+(7*3)+(6*9)+(5*1)+(4*8)+(3*6)+(2*6)+(1*8)=174
174 % 10 = 4
So 339186-68-4 is a valid CAS Registry Number.